Both drugs can independently cause tachycardia (increased heart rate), and together they may compound this effect, increasing the risk of arrhythmias and other cardiac events
Your GLP-1 prescription qualifies when it is treating one of these documented conditions: Type 2 diabetes Clinical obesity with a comorbidity (hypertension, sleep apnea, cardiovascular disease, or high cholesterol) Prediabetes or insulin resistance Polycystic ovary syndrome (PCOS) Non-alcoholic fatty liver disease (NAFLD) The critical requirement is documentation
Accessed 20 June 2024 Tran H, ElSayed MEH
It does sound like Hims is going down this path, with lots of language during Q2 on educating consumers around Hims capabilities across multiple dimensions
As of July 2026, Generic Semaglutide pens cost $199.99 USD per pen at Polar Bear Meds
This can be identified through tell-tale symptoms